- In July 2023, ASAHI INTECC Company Limited merged with Toyoflex Corporation, marking a significant strategic milestone for the company. This merger enabled ASAHI INTECC to diversify its assets and resources, enhancing its production capacity and expanding its market reach. The combined strengths of both companies are expected to improve operational efficiency and competitiveness in the industry
- In November 2023, Terumo Europe N.V. established a new subsidiary in South Africa as part of its global expansion strategy. This initiative is designed to strengthen the company's international presence while enhancing its strategic positioning in the market. The move aims to capitalize on growth opportunities and improve Terumo's competitive edge in the region
- In January 2022, Cardinal Health revealed its intention to sell Cordis to private equity firm Hellman & Friedman for $1 billion. This move coincided with the announcement of two strategic agreements aimed at enhancing Cordis, Cardinal Health's interventional vascular business, allowing it to broaden its cardiology product offerings in China. These initiatives reflect Cardinal Health's focus on strengthening its position in the global market
- In July 2021, Medtronic plc, a prominent player in medical technology, introduced the Prevail Drug Coated Balloon (DCB) catheter in Europe. This innovative catheter is designed for use in percutaneous coronary intervention procedures, specifically targeting narrowed coronary arteries in patients with coronary artery disease. The launch underscores Medtronic's commitment to advancing treatment options for cardiovascular conditions
- In February 2021, EchoNous announced that it received FDA clearance for its EchoNous Vein, an ultrasonic device designed to enhance the development of peripheral IV catheter replacements. This innovative technology aims to improve the accuracy and efficiency of IV catheter placements. The FDA clearance marks a significant step forward in EchoNous's mission to advance medical technology in vascular access
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Flow Directed Micro Guide Catheters and Over the Wire Micro Guide Catheters), Application (Cardiovascular, Neurovascular, Urology, and Other), End User (Hospital, Clinics, and Others) – Industry Trends and Forecast to 2031
.
The Global Micro Guide Catheters Market size was valued at USD 174.98 USD Million in 2023.
The Global Micro Guide Catheters Market is projected to grow at a CAGR of 7.63% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
